4598 — Delta-Fly Pharma Cashflow Statement
0.000.00%
Last trade - 00:00Annual cashflow statement for Delta-Fly Pharma, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -1,552 | -859 | -964 | -1,326 | -1,427 |
| Depreciation | |||||
| Non-Cash Items | 2.02 | 7.38 | 1.39 | 7.59 | 18.7 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -101 | 123 | 20.6 | 13.5 | 127 |
| Change in Accounts Receivable | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -1,649 | -727 | -940 | -1,303 | -1,280 |
| Capital Expenditures | -13.3 | -0.505 | — | -0.321 | -1.13 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | — | -0.005 | 1.34 |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -13.3 | -0.505 | — | -0.326 | 0.207 |
| Financing Cash Flow Items | — | 5.97 | — | 3.97 | 503 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 99.9 | 875 | 120 | 883 | 1,853 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1,565 | 145 | -820 | -424 | 573 |